Review Article
Changing patterns of sexually transmitted
infections in India [PDF]
VINOD K. SHARMA, SUJAY KHANDPUR
ABSTRACT
Sexually transmitted infections (STIs) are more dynamic than
other diseases prevailing in the community. Their epidemiological
profile varies from country to country and from one region
to another within a country, depending upon ethnographic, demographic,
socioeconomic and health factors. The clinical pattern is also
a result of the interaction among pathogens, the behaviours
that transmit them and the effectiveness of preventive and
control interventions. We reviewed the changing patterns of
different STIs (excluding HIV infection) in India and their
various risk factors.
A MEDLINE search was undertaken using the key words ‘sexually
transmitted infections, epidemiology, India’. Related articles
were also searched. In addition, a manual search for many Indian
articles, published in journals that are not indexed was also
carried out. Wherever possible, the full article was reviewed.
If the full article could not be traced, the abstract was used.
Most of the published data are institution based. There is a
paucity of community-based data, except for information obtained
from high risk groups such as commercial sex workers, truck drivers,
hotel workers and drug abusers. From the literature search undertaken,
it was observed that during the 1960s and 1970s, bacterial infections
including syphilis, chancroid and gonorrhoea were the major STIs,
while viral infections caused by herpes simplex virus and human
papillomavirus were so rare that they merited publication as
case reports. Since the 1980s, the spread of human immunodeficiency
virus (HIV) with subsequent behavioural (sexual and healthcare)
change, the indiscriminate and prophylactic use of over-the-counter
broad-spectrum antibiotics, upgradation of health services at
the primary level and the success of ‘syndromic’ approach
of treatment, has resulted in major changes in epidemiological
patterns. As in developed countries, there has been a rise in
viral and chlamydial infections and a relative fall in the incidence
of traditional infections. This has forced a reappraisal of the
importance of sexual and healthcare behaviours, since the control
of incurable viral STIs depends to a great extent on societal
efforts at primary prevention and counselling rather than their
early diagnosis and treatment, which is an effective strategy
against curable bacterial STIs.
Natl Med J India 2004;17:310–19
INTRODUCTION
Sexually transmitted infections (STIs) are perhaps as old as
human civilization itself. Medical descriptions of STIs date
back to the fifteenth century when syphilis and gonorrhoea were
primarily responsible for the abandonment of public baths in
Europe. After World War II, new diagnostic techniques and clinical
and epidemiological studies established that many ‘non-traditional’ microbes
could also produce infections when transmitted sexually. In the
USA, of the top 11 reportable diseases in 1996, 5 were transmitted
sexually (gonorrhoea, chlamydial infection, syphilis, hepatitis
B and acquired immunedeficiency syndrome [AIDS]). STIs are also
among the 5 leading causes of health problems in developing countries.1 The World Health Organization (WHO) estimated that in 1999, 340
million new cases of curable STIs occurred globally, of which
150 million cases were reported from South and Southeast Asia
including 50 million from India.2
The epidemiological profile of STIs is more dynamic than that
of other diseases. STIs differ from other diseases in the following
aspects: (i) their incubation periods are highly variable; (ii)
the genetic structure of most sexually transmitted pathogens
are so diverse that researchers have been unable to design a
vaccine against them; and (iii) these diseases are primarily
spread by a behaviour that is inherently resistant to change
because it is highly motivated and varies considerably within
and between social and ethnic groups.
A variety of demographic and medical factors contribute to the
high prevalence of STIs. The incidence and distribution of these
diseases are also influenced by factors such as lifestyle and
susceptibility of the individual, pathogenicity of the microbes,
prevailing therapy and disease control measures. A complex set
of behavioural factors also determine the risk of acquiring STIs.
The risk of acquiring STIs is high, especially in developing
countries such as India, where a large percentage of the population
belongs to the sexually active age group.3 Rural-to-urban migration
has led to family separation and unbalanced sex ratios in both
rural and urban areas, loss of traditional values of sexual behaviour
and increased sexual promiscuity. The stigma associated with
STIs is still strong and embarrassment may prevent infected persons
from seeking medical treatment, thereby increasing the reservoir
of infection. Moreover, cure after appropriate antibiotic therapy
is no longer certain for some infections such as gonorrhoea and
chancroid because of the increasing resistance of the microbes
to antibiotics.
In developed countries, there has been a steady increase in the
rates of STIs, especially viral STIs and genital chlamydial infection.
The development of more accurate diagnostic tests has helped
in the detection of widespread reservoirs of subclinical infection.
A rapid decline in the incidence of syphilis has been observed
in the Caucasian population with stable or even increasing rates
among blacks, especially among urban, poor and minority populations.4 Prostitution has emerged as a multiplier of STIs and the phenomenon
of sex in exchange for drugs has contributed to the epidemic
of syphilis, gonorrhoea and chancroid in North America. There
has been a constant decline in the incidence of gonorrhoea, especially
among heterosexual men and all women.5 However, it has been on
the increase in homosexual men.6,7
In developing countries, STIs account for 10%–20% of adult
patients attending government health facilities.8 However, these
figures are an underestimate, since such infections are rarely
treated in the public health sector, as patients prefer to visit
traditional healers, quacks, pharmacists or private practitioners
who are more accessible and less judgemental in their attitudes.
In India in the 1970s and early 1980s, syphilis and chancroid
were the main causes of genital ulcer disease (GUD), while viral
GUDs such as genital herpes were extremely rare. With the recognition
of human immunodeficiency virus (HIV) infection in the 1980s
and subsequent behavioural, social and psychological changes,
the pattern has shifted from predominantly bacterial to viral
STIs.
The epidemiological data on the STIs prevalent in India and their
risk factors were obtained by a thorough MEDLINE search using
keywords such as ‘sexually transmitted infections, epidemiology,
specific disease (syphilis, genital herpes, etc.)’. Also,
an exhaustive manual search of various journals in dermatology,
venereology, gynaecology, general medicine, community medicine,
paediatrics and microbiology (both full articles and abstracts)
was also done.
EPIDEMIOLOGY OF bacterial STIs
Syphilis
It is a major cause of GUD and an important risk factor in the
transmission of HIV infection. In developed countries, the prevalence
of syphilis has fallen steeply except for a few focal outbreaks.
This is due to improved access to healthcare, effective control
programmes and efficacious treatment. However, in some developing
countries, it remains a major public health problem with an estimated
12 million cases occurring worldwide annually, of which 4 million
occur in Africa.2
In the USA, syphilis is characterized by spontaneous epidemics
rather than persistent endemicity with an estimated 70 000 cases
of syphilis occurring annually.9 The incidence of primary and
secondary syphilis in 1984–94 ranged from 0 to 87 per 100
000 population. The decline began in 1991 and in 2000 it was
2.2 per 100 000.10–12 However, syphilis is re-emerging
among men who have sex with men (MSM). The focal outbreaks during
1997–98 and 1999–2000, especially in Chicago, New
York, Boston, Miami, Seattle and San Francisco were among this
group (comprising 68% of syphilis cases), of which two-thirds
were HIV positive.13
In England and Wales, after almost 2 decades of a persistent
decline, infectious syphilis is again on the rise.14 Since 1997,
when the Bristol outbreak heralded a resurgence of the disease,
outbreaks have been reported in the Northwest, Southeast and
London regions of England. By 2000, nearly two-thirds of the
nationally reported cases were diagnosed in these areas. In 1999–2000,
the infection rose by 160% in men (from 153 to 248 cases), 130%
in women (from 55 to 73 cases), and 217% in MSM (from 52 to 113
cases). These outbreaks were associated with high rates of partner
exchange, travel to or migration from endemic areas, predominance
of homosexuality and a high proportion of HIV co-infection. Resurgence
of syphilis has also been reported from other European countries.
In the STI clinics in Amsterdam, the Netherlands in 1999, 76
new cases of infectious syphilis were reported, an increase of
111% from 1998, with the largest increase being among MSM (from
9 in 1998 to 40 in 1999).15
In India, syphilis continues to be a major health problem. However,
a constant decline in its prevalence has been observed in recent
years. In a retrospective analysis of the data obtained from
STI clinic attendees at a tertiary hospital in Delhi between
1954 and 1994, although the STI cases increased 8-fold, with
the prevalence increasing from 5.5% in 1964 to 14.7% in 1994,
the syphilis load declined from 61.2% to 9.1%.16 Men outnumbered
women in the ratio of 2.8:1, probably because women report for
investigations and treatment much later than men, due in part
to the asymptomatic nature of the disease in women. In this analysis
it was also observed that the prevalence in adult men increased
until 1984 in contrast to children under 14 years of age, in
whom it decreased from 12.6% in 1954 to 0.5% in 1994. No case
of neurosyphilis was diagnosed during the 40-year study period
while 10 cases of cardiovascular syphilis were last reported
in 1954. In other Delhi hospitals also, the syphilis load had
decreased from 54.9% in 1965–78 to 15.6% in 1995–99.17,18 During 1965–78, 2 cases each of neurosyphilis and cardiovascular
syphilis in women were reported.18 In Madurai, Tamil Nadu in
1992, 17.5% of men presenting with neurological manifestations
and an associated past history of multiple sex partners were
diagnosed as having neurosyphilis, predominantly meningovascular
syphilis.19 A major decline in syphilis has been observed in
Chandigarh, with the prevalence decreasing from 10.4% in 1977–85
to 2% in 1995–96,20,21 in Rohtak from 30.2% in 1992–93
to 24% in 1995–200022–24 and in Patiala from 29.6%
in 1983–88 to 17.2% in 1990–98.25,26 This reduction
may be attributed to the regular supply and consistent use of
effective drugs. A cross-sectional survey of women in the reproductive
age group in an urban slum community in Mumbai in 1995 reported
a venereal disease research laboratory (VDRL) seropositivity
of 0.5%, while a study from a similar population in Delhi in
1996–2000 showed a seropositivity of 4%.27,28
Blood donors may also acquire and transmit syphilis (Table I).
In our hospital, between 1989 and 1995, VDRL reactivity among
voluntary and replacement blood donors increased from 0.23% to
0.52%.30 A survey undertaken in Vellore, Tamil Nadu showed that
seroprevalence among blood donors decreased between 1990 and
1995 and then increased in the next 3 years.47 In other parts
of India, VDRL positivity has been observed to vary from 0% in
Lucknow and Shimla, and 0.095% in Ludhiana to as high as 7% in
Bihar.29,33–39,42,43
Table I. Venereal diseases research laboratory (VDRL) positivity
in India
City |
Year |
Blood donors (%) |
Antenatal women (%) |
Delhi29 |
1987 |
2.8 |
- |
Delhi29 |
1989 |
0.23 |
- |
Delhi29 |
1995 |
0.52 |
- |
Delhi29 |
1996 |
- |
3.4 |
Delhi29 |
1998 |
- |
2.53 |
Lucknow33 |
1996 |
0 |
- |
Tirunelvelli34 |
1985 |
3.62 |
- |
Bihar35 |
1993 |
7 |
- |
Jodhpur36 |
1994–99 |
0.22 |
- |
Ludhiana37 |
2002 |
0.095 |
- |
Trivandrum38 |
1994–99 |
0.2 |
- |
Chandigarh39 |
1996 |
0.11 |
- |
Chandigarh39 |
2002 |
0.66 |
- |
Chandigarh39 |
1986 |
- |
1.8 |
Chandigarh39 |
2003 |
- |
0.67 |
Shimla42 |
1987–90 |
0 |
- |
Bijapur43 |
1996–2001 |
0.57 |
- |
Aligarh44 |
1987 |
- |
2.9 |
Rohtak45 |
1996–2000 |
- |
1.47 |
Vellore46 |
2001 |
- |
0.98 |
Congenital syphilis (CS)
is the most dreaded consequence of untreated syphilis in pregnant
women, and is estimated
to occur in 25%–75% of exposed infants.48 It has been suggested
that approximately 10%–12% of infants born to mothers with
a positive serology for syphilis would die if untreated, yielding
a mortality rate of 1%–3% among children under the age
of 4 years. In Delhi, during 1965–78, 82 cases of CS were
reported, with a higher female-to-male ratio (1.73:1).18 In Kurnool,
Andhra Pradesh, only 7 cases of CS were observed from 1980 to
1990.49
Surveys conducted among antenatal women have shown VDRL seropositivity
to vary from 0.67% in Chandigarh to 3.4% in Delhi (Table I).
Gonorrhoea
This is a well recognized public health problem and remains
one of the commonest bacterial STIs in the world, with approximately
62 million new Neisseria gonorrhoeae infections occurring annually
worldwide.50 The importance
of this disease is not only limited to its high incidence and
acute manifestations, but also extends
to the complications and disturbing sequelae. It is also an
important risk factor for the transmission of HIV infection.
In developed countries, there has been a constant decline in
the incidence of gonorrhoea. However, in developing countries,
the prevalence is high. In India, the prevalence of gonorrhoea
among STI clinic attendees in different regions varies from
3% to 19% (Tables II and III). However, it has been on the
decline
over the past decade, probably due to the availability of medical
facilities at the primary healthcare level, indiscriminate
use of potent over-the-counter drugs for unrelated illnesses,
prophylactic
use of antibiotics after sexual exposure and growing awareness
about AIDS. A steady decline in prevalence was observed in
Chandigarh, Delhi and Patiala, while a marginal increase was
reported from
Rohtak and Ahmedabad (Tables II and III). In a survey of women
attending an STI clinic in Mumbai in 1996, 9.7% were positive
for gonorrhoea.60 This was higher than that reported from gynaecological
clinics in Amritsar (1995) and Chandigarh (1986), where it
was 0.8% and 1.8%, respectively.61,62 The
apparent ratio of male-to-female cases is 10:1 with 80%–90% of men acquiring the infection
from commercial sex workers (CSWs).63
Table II. Trends (%) in sexually transmitted
infections (STIs) among STI clinic attendees in tertiary hospitals
in India
Year |
Syphilis |
Chancroid |
LGV |
Donovanosis |
HSV |
HPV |
Gonorrhoea |
NGU |
Chandigarh |
1977–8521 |
10.4 |
12.2 |
0.6 |
6.3 |
11.4 |
21.4 |
16.9 |
4.1 |
1985–9220 |
8.7 |
8.1 |
0.9 |
1.6 |
19.7 |
25.2 |
5.3 |
4.1 |
1995–9651 |
2 |
3 |
6 |
0.5 |
21 |
7 |
3 |
6 |
Delhi |
1955–6151 |
7.3 |
22.5 |
0.6 |
0.25 |
- |
- |
15.9 |
4.9 |
1965–7818 |
54.9 |
5.9 |
0.9 |
1.2 |
2.5 |
2 |
1.9 |
- |
1989–9552 |
14.3 |
23.9 |
1.6 |
1.4 |
11.8 |
9.2 |
12.2 |
3.7 |
1995–9917 |
15.6 |
11 |
0.45 |
0.48 |
11.8 |
9.3 |
11.6 |
7.4 |
Patiala |
1983–8826 |
29.6 |
8.8 |
0.2 |
0.2 |
11.6 |
12 |
10 |
5.2 |
1990–9825 |
17.2 |
1.6 |
0.15 |
0.28 |
9.4 |
5.1 |
4.2 |
10.8 |
Rohtak |
1992–9424 |
30.2 |
22.1 |
0.97 |
1.45 |
10.6 |
18.1 |
12.9 |
4.7 |
1995–9622 |
7.4– P |
|
|
|
|
|
|
|
|
17.5– S |
14.5 |
0.67 |
0.8 |
11.1 |
21.5 |
12.6 |
6.7 |
1995–200023 |
24 |
10.9 |
0.2 |
0.86 |
16.9 |
19.4 |
16.2 |
4.8 |
Ahmedabad |
1993–9453 |
22.2– P |
|
|
|
|
|
|
|
|
28.7– S |
7.6 |
0.58 |
2 |
8.2 |
7.2 |
5.05 |
- |
1998–9954 |
28.9 |
9.6 |
- |
1 |
27.9 |
9.1 |
12.7 |
1.5 |
Others |
Kurnool55 |
|
|
|
|
|
|
|
|
1992–96 |
14.4 |
2.8 |
9.7 |
- |
14 |
11.3 |
11.7 |
19.1 |
Pondicherry56 |
|
|
|
|
|
|
|
|
1982–90 |
18 |
10.6 |
8 |
8.2 |
14.1 |
11.9 |
11.9 |
0.8 |
LGV Lymphogranuloma venereum HSV herpes simplex
virus HPV human papillomavirus NGU non-gonococcal urethritis
Table III. Trends (%) in
sexually transmitted infections (STIs) among STI clinic attendees
in district hospitals in India |
Region |
Syphilis |
Chancroid |
LGV |
Donovanosis |
HSV |
HPV |
Gonorrhoea |
NGU |
Srinagar57 1986–94 |
20.8 |
28.8 |
9.7 |
0.2 |
4.1 |
11.25 |
11.7 |
2.6 |
Port Blair58 1992–93 |
25.4 |
21.1 |
- |
- |
7.7 |
9.2 |
19 |
7.04 |
Tezpur59 1986–90 |
14.6 |
35 |
10 |
0.013 |
5 |
9.2 |
17.1 |
3.3 |
LGV Lymphogranuloma venereum
HSV herpes simplex virus HPV human papillomavirus NGU non-gonococcal
urethritis |
Chlamydial infection
Genital Chlamydia trachomatis infection is an STI of epidemic
proportions. It causes up to half of all acute non-gonococcal
urethritis (NGU) and at least one-third of acute epididymitis
in men. In women, it is responsible for half of all cases of
mucopurulent cervicitis and 20%–40% of cases of pelvic
inflammatory disease (PID) with a risk of subsequent infertility
or ectopic pregnancy.64 In 1997, 89 million new chlamydial
infections were detected and WHO estimates that the global
frequency of the infection is 50 million cases per year.2,65 In the USA, it is the commonest nationally notifiable infectious
disease, with 3 million cases occurring annually.9 The majority
of epidemiological studies conducted in India have used the
criterion of demonstration of >5 neutrophils in urethral
smears or endocervical specimens to establish the diagnosis
of NGU, without isolating the causative organism. The prevalence
using this criterion varies from 1.5% to 19% among STI clinic
attendees in different parts of the country (Tables II and
III). There are only a few studies in which the disease prevalence
has been established by specific diagnostic modalities. Among
STI clinic attendees in Delhi in 1998–99, 50% positivity
for C. trachomatis was found using the plasmid-based polymerase
chain reaction (PCR) assay, 26% positivity using enzyme immunoassay
for antigen detection and 52% positivity using enzyme-linked
immunosorbent assay (ELISA) for antibody detection.66
Among antenatal clinic attendees (Table IV) in Delhi in 1999,
21.3% were found to be infected with C. trachomatis, with high
incidences of stillbirths, prematurity and low birth-weight.67 Another study from Delhi in 1999 showed a prevalence of chlamydial
infection in 17% and 18.6% of the cases during mid-pregnancy
and labour. However, there was no difference in neonatal complications
due to the infection except for purulent conjunctivitis as compared
with the control group.68
In women attending gynaecological clinics (Table IV) in a Delhi
hospital between 1990 and 1992 with symptoms of lower genital
tract infection and infertility, the prevalence was 41% and 36%,
respectively.69 In young women undergoing a routine gynaecological
check-up in Mumbai in 1994, genital chlamydial infection was
diagnosed in 15% of cases; 53% of cases showed clinical signs
suggestive of cervicitis and only 2% had PID.71 In this study,
the contribution of C. trachomatis to PID was much lower compared
with a study from Nagpur, in which it was responsible for 33%
of cases with PID.78 This infection was detected in 23.3% of
attendees of the gynaecological clinic of an outpatient department
(OPD) in Delhi in 1994.70 Among women seeking healthcare for
reproductive health complications, chlamydial infection rates
of 0.3%–3.2% and 23.3%–33% have been reported from
different parts of India.72,73 The risk factors include a low
socioeconomic status, multiple sexual partners and the use of
intrauterine devices, while the protective factors are a higher
age group and the use of oral and barrier contraceptives.
Table IV. Prevalence of Chlamydia trachomatis
infection in India and some other countries |
Country |
Year |
Antenatal clinics (%) |
Attendees of gynaecology clinics (%) |
India |
Delhi67 |
1999 |
21.3 |
- |
Delhi68 |
1999 |
17–18.6 |
- |
Delhi69 |
1990–92 |
- |
36–41 |
Delhi70 |
1994 |
- |
23.3 |
Mumbai71 |
1994 |
- |
15 |
Mumbai72 |
2000 |
- |
14.3–20 |
Chandigarh73 |
1989 |
- |
33 |
USA74 |
1990s |
5 |
- |
UK75 |
1990s |
3–4 |
- |
China76 |
1993 |
3 |
- |
The Philippines |
1994 |
5.6 |
- |
Thailand77 |
1999 |
6.8 |
- |
Chancroid
The epidemiological data for chancroid may be inaccurate in view
of the difficulty in diagnosing the condition on clinical grounds
alone, since most medical service providers do not have the
facility to perform laboratory tests. Recently, chancroid has
received more attention because of its strong association with
HIV transmission. In developed countries, it is an uncommon
cause of GUD.
Chancroid is the leading cause of GUD in developing countries,
particularly in sub-Saharan Africa and Southeast Asia. In African
countries, its prevalence varies from 9.8% to 68%.79 The risk
factors include early age at first coitus, long duration of marriage
(>20 years), large number of lifetime sexual partners, serological
evidence of exposure to another STI and lower socioeconomic status.
The incidence is highest among divorcees and CSWs. In India,
the prevalence was observed to vary from 1.6% in Patiala to as
high as 51.9% in Mumbai.25,80 On comparing the rates from the
same region during different periods, a considerable decrease
in the prevalence was observed (Tables II and III). This may
be due to the availability of newer antibiotics, their indiscriminate
use at the primary care level due to free availability, their
prophylactic use before or after sexual exposure, greater awareness
regarding early diagnosis and treatment, and the immense success
of the syndromic approach in the treatment of STIs and condom
promotion campaigns.
Donovanosis
This is a chronic, mildly contagious STI characterized by granulomatous
ulceration of the genitalia and neighbouring sites caused by
Calymmatobacterium granulomatis. It has been ignored as a cause
of GUD for many years due to the non-availability of specific
laboratory diagnostic facilities. However, during the past decade,
there has been a renewed interest owing to the emergence of HIV
infection and the consequent increase in the number of cases
of donovanosis. Although donovanosis has a worldwide distribution,
it is endemic in tropical and subtropical countries, especially
in India, Papua New Guinea, Brazil, South Africa and among aborigines
of Australia. Racial and ethnic predispositions are associated
with it since it is more common among Dravidians in southern
India and hill dwellers of Himachal Pradesh.81 The disease has
been frequently reported from some parts of India, especially
Tamil Nadu, Pondicherry, Andhra Pradesh and Orissa. It is speculated
that in these states, climatic factors such as moderate relative
humidity and persistent high temperatures are responsible for
the higher prevalence. A strong association with HLA-B57 has
also been observed.82 In various STI clinics, the prevalence
ranged from 0.013% in Tezpur59 to 8.2% in Pondicherry56 and 10%
in Mumbai.83 In Chandigarh, the prevalence showed a major decline
from 6.3% in 1977–8521 to 0.5% in 1995–96,84 probably
due to the availability of broad-spectrum antibiotics. In Delhi,
it increased from 0.25% in 1955–6151 to 1.4% in 1989–9552
and then declined to 0.48% in 1995–99.17 Two epidemics
of donovanosis occurred in Delhi, in 1983 and 1985, when the
reported incidences were 6.38% and 8.33%, respectively.85 The
disease mainly affected young, unmarried men who contracted the
disease during heterosexual intercourse with CSWs, and those
who were illiterate and from low socioeconomic groups. The increase
in incidence was also attributed to the large-scale migration
of high risk individuals from endemic areas.
Lymphogranuloma venereum (LGV)
It is a less commonly encountered STI in developed countries,
with only sporadic cases reported from North America, Europe
and Australia, where it occurs mainly among immigrants and travellers
returning from endemic areas.86 In India, a prevalence of 0.15%–9.74%
has been reported from different parts of the country (Tables
II and III). Perhaps the lack of specific diagnostic criteria
in these studies and the relatively poor degree of clinical suspicion
of the condition may have introduced some bias in these estimates.
Bacterial vaginosis
This is a common cause of abnormal vaginal discharge in women
of reproductive age, and an established risk factor for premature
rupture of the membranes and preterm delivery. In recent studies,
a very high prevalence of bacterial vaginosis has been reported
among those attending antenatal and gynaecological clinics, varying
from 26% to 50% in women with symptomatic vaginitis and from
11.5% to 22.2% among asymptomatic women.87–91 In two community-based
surveys conducted in the districts of Haryana and Karnataka among
ever-married women in the 15–44 years age group, and in
married women with 6–12-month-old children, respectively,
bacterial vaginosis was detected in 48% of women complaining
of vaginal discharge in the first survey and in 18% in the second
survey.90,91 The attributable risk of preterm delivery associated
with bacterial vaginosis has been observed to be as high as 82.5%.88
This infection strongly correlates with sterilized women in urban
areas, long duration of marriage, lower socioeconomic status
and women with more than two children.
EPIDEMIOLOGY OF Viral STIs
Genital herpes infection
Genital herpes simplex virus (HSV) infection is the second most
prevalent STI worldwide and the commonest cause of GUD in the
developed world.92 This infection has important public health
implications because: (i) undiagnosed cases contribute to the
population reservoir and transmission of the virus; (ii) perinatal
transmission to the neonate may result in disseminated disease,
neurological damage and high mortality; and (iii) herpetic ulcers
facilitate HIV transmission.
Genital herpes is one of the three most prevalent STIs in the
USA (along with chlamydial and human papillomavirus infections),
and probably of greatest concern to sexually active people, apart
from HIV infection.93 In the USA, about 1 in 5 persons >12
years of age (approximately 45 million people) are infected with
HSV-2 infection with up to 1 million new HSV-2 infections occurring
annually. There has been a constant increase both in the incidence
and prevalence of genital herpes. In India also, there has been
a major increase in the proportion of viral STIs, especially
HSV infection, with rates varying from 4.1% to 27.9% among STI
clinic attendees in different regions of the country (Tables
II and III). In Chandigarh, the prevalence rose from 11.4% in
1977–85 to 21% in 1995–96.20,21 In Ahmedabad, it
increased from 8.23% in 1993–94 to 27.9% in 1998–99,53,54
and in Delhi, from 2.5% in 1965–78 to 11.8% in 1995–99.17,18
In Pune, in 1994, 26% of patients with GUD had herpes as the
aetiological cause, which was diagnosed using the multiplex-PCR
technique.94 In Nagpur, in 1998, the seroprevalence of HSV-2
among GUDs was 40.2%.95 During 1983–86, genital herpes
was diagnosed in 19% of STI clinic attendees in southern India,
with a positive culture in 38.7% of the cases with primary infection
and 38.2% with recurrent disease.96 In a cross-sectional study
of gynaecological clinic attendees in a Delhi hospital in 1994,
IgA antibodies to HSV were detected in 20.6% of the women.70
Human papillomavirus (HPV) infection
Genital HPV infects the epithelial lining of the anogenital tract.
Of the 100 HPV types identified, approximately 30 have affinity
for the anogenital tract. Genital HPV infection is the commonest
viral STI in the developed world, with an estimated 30 million
new cases diagnosed annually worldwide.97 Approximately 15% of
the general population harbours subclinical infection.98
In India, the incidence of genital warts has been reported to
vary from 2% to 25.2% among STI clinic attendees (Tables II and
III). The data collected from various clinics show contradictory
trends. In Delhi, in 1955–61, no case was reported,51 the
prevalence in 1965–78 was 2%,18 which increased to 9.3%
in 1995–99.17 In women attending gynaecological OPDs in
Delhi in 1994, HPV was found to be the leading infection, affecting
49.4% of women.70 In Rohtak, during the 1990s, it marginally
increased from 18.1% to 21.5% and then declined to 19.4%.22–24
Similarly, in Ahmedabad, a slight increase was observed from
7.2% in 1993–94 to 9.1% in 1998–99.53,54 However,
in Chandigarh and Patiala, the prevalence of genital warts had
declined. These studies were based on clinical diagnosis only,
rather than the detection of HPV DNA or serological tests. The
subclinical and asymptomatic nature of HPV infection, especially
in women, may have been responsible for the wide disparity in
the incidence rates.
Infection with oncogenic HPV is the leading cause of cervical
cancer in India. In a study from Delhi during the late 1990s
among women STI clinic attendees, HPV-16 DNA was detected in
30% of cases, which increased to 52% and 72% among women with
precancerous and cancerous cervical lesions, respectively.66 In Mumbai, using southern hybridization of the HPV PCR product
by HPV-16/18 probes, HPV-16/18 was detected in 77% of cervical
cancer patients, 38% of patients with low grade squamous intraepithelial
neoplasia lesions (SIL), 80% of patients with high grade SIL
and 15.2% of healthy women.99 In another study from Mumbai, using
the non-isotopic in situ hybridization technique, HPV DNA was
detected in 76.4% of patients with cervical cancer lesions; HPV-16/18
in 29.4% of cases with squamous cell carcinoma, and only HPV-18
in all cases of adenocarcinoma and neuroendocrine carcinoma of
the cervix.100 HPV-16 was isolated in 29.1% and HPV-18 in 8.3%
of patients with SIL lesions. In Kolkata, HPV DNA was detected
in 50% of biopsy specimens and in none of the exfoliative cervical
cell specimens of patients with carcinoma of the cervix; HPV-16/18
was isolated from 56% of the positive biopsy material.101
In a majority of the studies cited above, the risk of acquiring
HPV infection, especially among cytologically normal women, was
inversely related to age and directly to the number of sexual
partners, poor socioeconomic status, low education, use of oral
contraceptives, reproductive characteristics, concomitant presence
of other STIs, smoking and dietary factors. In the early 1990s,
a high rate of prevalence was reported among the adolescent population,
ranging from 15.6% to 46%.102 The inverse association with age
may be explained by the fact that the immunological or hormonal
changes occurring in old age may clear or suppress existing infection.
Moreover, fewer sexual partners in older women may reduce the
rate of infection. In a study from Japan, the risk of acquiring
premalignant and malignant cervical lesions with HPV-16 was 8
times higher in women £44 years of age than in women ³45
years of age.103 The use of oral contraceptives may influence
the transcription and translation of the HPV genome and hence
play an important role in the causation of cervical neoplasia.
Ethnographic variations have also been observed in the epidemiology
of HPV infection.104 Higher rates of prevalence have been reported
among African/American women than among whites or Hispanics.
This may be due to differences in the probability of encountering
an HPV-positive partner, genetic predisposition towards a greater
susceptibility to the acquisition and persistence of infection,
endogenous hormonal factors or differences in sexual behaviour
among the ethnic groups.
Hepatitis B virus (HBV) infection
This is an important viral infection in India, transmitted predominantly
via the parenteral, percutaneous or perinatal route. Many studies
also suggest sexual contact as a possible mode of transmission
both in homosexual and heterosexual individuals.105 In fact,
very high hepatitis B surface antigen (HBsAg) positivity has
been observed in homosexual patients with STIs.106
India falls in the intermediate zone of HBV prevalence (between
2% and 7%) based on surveys among blood donors, intravenous drug
abusers, other high risk groups, pregnant women and the general
community.107
Among voluntary and replacement blood donors, a prevalence of
1%–4% in most regions, with a rate of 7% in Chennai has
been reported.108,109
In pregnant women attending antenatal clinics, HBsAg positivity
of 2.3%–5% has been recorded,109–111 while in healthcare
workers (HCW), it has been found to vary from 1.7% to 5.3%.112,113 Among HCW, laboratory technicians showed the highest positivity
of 40% in a study from Shimla.114
Tandon et al. have reported an HBV carrier rate of 2%–8%
in the north Indian population.115 In various community surveys,
HBsAg positivity of 3.4%–11.3% has been observed.116,117 Certain tribal communities are endemic for this infection. In
the tribal regions of Madhya Pradesh, a prevalence of 4.4% and
15.7% has been found,118,119 while in the two tribes (Nicobarese
and Jarawas) of the Andaman and Nicobar islands, an HBsAg positivity
of 22.3% and 60%, respectively, was recorded.120,121 Horizontal
transmission through close contact with carriers, the perinatal
route and use of unsafe injections were the common modes of transmission
in this population.
Prevalence rates in high risk populations including drug abusers,
STI clinic attendees and prisoners have also been reported from
different regions. In Manipur, 100% HBsAg positivity was found
in HIV-positive intravenous drug abusers.122 In two surveys of
prison inmates in Delhi, HBV infection was found in 12% and 34%
of the cases.123,124 HBsAg positivity among patients with STIs
has been shown to vary from 2.6% to 21.7% in different parts
of India.125,126 However, in a study from Chandigarh, the HBsAg
positivity in patients with STIs was not significantly different
from controls (14.8% in STI cases and 9% in controls), suggesting
a high endemicity of HBV infection in the region and emphasizing
that sexual contact is probably not the major route of transmission.127
Hepatitis C virus (HCV) infection
This is a global public health problem affecting 3% of the world’s
population. Its transmission is primarily attributed to contact
with infected blood or unsterile needles. There is also evidence
of sexual transmission of HCV infection which is facilitated
by ulcerative STIs and homosexual practices.128 Among blood donors,
the worldwide prevalence of HCV infection ranges from 0.01% to
2% and in India, 0.08%–4% of non-professional blood donors
have been found to be infected.29,129 Among HCW, in Chandigarh,
HCV seropositivity was reported in 0.9% but in Shimla and Madurai
there was no evidence of infection in this group.112–114
In high risk cases such as prisoners, HCV infection was reported
in 4.8%–16% of cases.123,124 In Manipur, 92% of HIV-positive
intravenous drug abusers were positive for HCV.122 A very high
prevalence of anti-HCV antibody was observed among those undergoing
haemodialysis (27.8% in Mumbai, 42% in Indore) and receiving
multiple blood transfusions (36.4% in Mumbai, 25.5% in Indore).130,131 In a community-based survey in a district of West Bengal in 1999,
0.9% of cases were positive for anti-HCV antibody.132 The age-specific
prevalence was low in children (0.3%), but increased progressively
in adolescents (0.8%), adults (1%) and the elderly (1.9%), suggesting
a steady cumulative rise in the incidence of infection. A very
high prevalence of anti-HCV antibody (7.9%) was reported among
the Lisu community of Arunachal Pradesh in 1999–2000, of
whom 75% were illiterate and 92% cultivators.133
The above studies suggest that the prevalence of bacterial STIs
is decreasing while that of chlamydial and viral infections is
increasing. Community-based data from Tamil Nadu on the prevalence
of STI also indicate a similar trend (Table V).134
Table V. Community prevalence
(%) of sexually transmitted infections (STIs) in Tamil Nadu134 |
Genital symptoms |
47.3 |
Genital discharge |
52.5 women; 1.7 men |
Vaginal discharge, abdominal pain, dyspareunia |
60 women |
Asymptomatic infection |
32 women; 72 men |
STI syndromes |
|
Genital ulcer disease (men) |
0.1 |
Genital ulcer disease (women) |
2.7 |
Vaginal discharge |
41.5 |
Urethral discharge (men) |
0.2 |
Bubo (men) |
0.02 |
Scrotal swelling |
2.5 |
Pelvic inflammatory disease |
0.6 |
Pattern of STIs |
|
Any STI |
15.8 |
Classical STI |
9.7 |
Gonorrhoea |
3.7 |
Syphilis |
0.3 |
Chlamydia infection |
3.9 |
Trichomoniasis |
5.1 |
Hepatitis B surface antigen positivity |
5.3 |
HIV infection |
1.8 |
STIs IN HIGH RISK GROUPS
Commercial sex workers (CSWs)
A CSW is defined as a person who provides sexual service for
money or other material gains and includes those who work in
brothels or are casual freelance sex workers. They may also
work in night clubs, hotels, massage parlours or bars. Contact
with
CSWs is an important risk factor for the transmission of STIs
because they have a high rate of partner change, longer period
of exposure to infection, poorer access to healthcare facilities
and efficient transmission from sexual exposure.
In India,
a majority (74.5%–89%) of men attending an STI
clinic give a history of contact with CSWs. In Kolkata, in 1994,
a very high prevalence of STIs (80.6%) was observed in this group.135 Oral infection with HSV-1, HSV-2 and HPV-16/18 was detected in
24.6%, 11.6% and 29% of CSWs, respectively, while cervical infection
occurred in 0%, 44% and 63%, respectively, indicating a high
prevalence of oral sex in this group. In a 1996 survey of ‘clients’ visiting
the ‘red light’ area of Kolkata, HCV seropositivity
was found in 15.1% of cases, HBsAg in 40.9% and syphilis in 20.4%.136 In Pune, of the 200 CSWs surveyed randomly, 81.5% suffered from
an STI.137 Syphilis was the commonest infection (36.8%) followed
by chancroid (31.3%). Forty-seven per cent of CSWs were HIV positive
compared with 14% of controls. A survey of CSWs from Tirupati
in 1992–93 showed HIV seropositivity in 25%, primary
chancre in 15%, gonorrhoea in 15%, LGV in 10%, donovanosis
in 5%, seropositivity
for syphilis in 70% and HBsAg in 50%.138
It is estimated that by 2005, HIV infection among CSWs in
India would increase to 3.93 million from 2.49 million in
1999 in
a favourable scenario, and to 6.87 million under a worst-case
scenario
unless prevention strategies are enforced in this high risk
group.139 Hence, their continuous surveillance, early diagnosis,
appropriate
treatment and rigorous follow up is of utmost importance
in limiting the transmission of STIs. Moreover, the focus
is on
STI prevention
by using barrier contraceptives.
Transport workers (drivers)
This group is at a high risk of acquiring and transmitting an
STI (including HIV) because of their geographical mobility.
They often come in contact with CSWs, including homosexuals,
while they are away from their families for long periods. Poverty,
illiteracy and a low level of awareness about STI and HIV,
and the lack of healthy recreational facilities are other contributing
factors. In a study conducted in Pondicherry between 1997 and
1999, truck drivers had the highest rates of HBsAg positivity
(23.8%) and HIV infection (47.6%) and the second highest rate
of HCV positivity (42.8%).140 In another survey from the same
city between 1993 and 1997, 51.4% of truck drivers were seropositive
for HIV antibodies.141 In Nagpur, 43.7% of long-distance truck
drivers had one or more STIs—HIV infection in 15.2%,
syphilis in 21.9%, gonorrhoea in 6.7% and HBV in 5.1%.142 In
Delhi in 1990, 1% of truck drivers were HIV positive.143 The
risk behaviours included sex with CSWs, homosexuality, illiteracy
and non-usage of condoms.
Restaurant workers
They are another high risk group that transmits STIs. In a survey
undertaken among this group along a highway in Assam, over one-third
had sexual contact with multiple partners or CSWs and 2% were
engaged in homosexual activity. A majority of them were illiterate,
30% were alcoholics and smokers, and 3% were addicted to cannabis.144 GUD was present in 25.7% of the workers, 11.8% had gonorrhoea
while 5.1% were VDRL reactive.
Trans-sexuals
In the Indian subcontinent, male sex workers are predominantly
transvestites and trans-sexuals. This community engages in commercial
sex that comprises mainly insertive anogenital intercourse with
men. STI prevalence in this group has been formally studied in
Pakistan, although this group is active in India as well and
forms an important source of STI transmission. A survey conducted
in Karachi in 1999 documented syphilis in 37%, urethritis in
70%, genital warts in 54% and HBsAg positivity in 3.4% of the
transvestite sex workers.145 Fifty-seven per cent of these individuals
reported sexual abuse in childhood, the average age of first
intercourse with consent was 12 years and the use of condoms
by their sexual partners was minimal. Almost 50% of these individuals
took drugs and 63% consumed alcohol.145 Hence, intervention strategies
for this community can have a major impact on the prevention
of STIs and HIV infection.
Prison inmates
STIs tend to cluster in socially excluded populations and such
populations are over-represented in prisons. Numerous studies
have found high rates of STIs among prison inmates. Moreover,
the spread of HIV, HBV and HCV is linked to a higher imprisonment
rate of drug abusers. An epidemiological study in a district
jail around Delhi showed that 4.6% of inmates had primary syphilis,
33.3% were positive for HBsAg, 5% were reactive for HCV antibodies
and 1.3% were Western blot-confirmed HIV-1 positive cases;123
28.8% of the inmates were homosexuals/bisexuals, 54.2% gave a
history of multiple sexual partners, 83% had had contact with
CSWs and 80.6% indulged in unprotected sex. Of the inmates, 68%
were alcoholics, 24% consumed heroin while 4.8% were intravenous
(i.v.) drug abusers.
Substance abusers
Substance abusers have been associated with epidemics of STIs,
especially HIV infection.
Crack cocaine users. The drug most often associated with STIs
is smokable freebase (crack) cocaine. Ethnographic research suggests
that addiction to crack forces young women to sell sex directly
for money to buy crack. Also, sex workers, under the influence
of the drug, may be less careful when indulging in sexual practices
or choosing partners. Epidemiological data indicate that ‘crack
for sex’ exchange differs from other types of prostitution
because a high proportion of the adolescent population are drug
abusers, oral sex is the predominant type of sexual activity
and crack users often indulge in unprotected sex.146 A high prevalence
of STIs in this group has been reported from various parts of
the USA. The use of crack cocaine could have a serious impact
on the patterns of STIs in India as well, and necessary legislative
measures need to be adopted to stop its use and prevent STIs.
Intravenous drug abuse. Epidemiological studies among intravenous
drug abusers have shown a high frequency of blood-borne STIs
including HIV, HBV and HCV infections and syphilis. In Manipur,
in 2000, the prevalence of HIV among intravenous drug abusers
was 80% and vaginal discharge was strongly associated with HIV
positivity.147 A study of sexual behaviour among drug abusers
in Delhi showed a higher number of sex partners, higher rate
of anal intercourse (25.7%) and an increased frequency of visits
to CSWs leading to a significantly higher prevalence of STIs.148
Alcoholism and smoking. Smoking has been shown to be strongly
associated with the persistence of oncogenic HPV cervical infection.
Adolescent women with alcohol use disorder in the USA appeared
to be at a substantially high risk for HSV-2 infection, with
a seroprevalence of 19% compared to 10% in those without this
disorder.149
CONCLUSION
The studies cited above suggest that, across the country, the
prevalence of bacterial STIs is decreasing while that of chlamydial
and viral infections is increasing. The decline in bacterial
infections may be attributed to the indiscriminate and prophylactic
use of over-the-counter broad-spectrum antibiotics, upgradation
of health facilities at the primary level and greater awareness
about AIDS. Social factors such as separation from home at
an early age in search of job opportunities in big cities,
lower level of education, sex at an early age, premarital sex,
multiple sexual partners and frequent visits to CSWs have led
to a relatively high prevalence of STIs. The epidemiology of
STIs depends upon several complex yet distinct and interrelated
behavioural, sociodemographic, economic, geographical and ethnic
factors. A comprehensive knowledge of the various epidemiological
factors is essential to design preventive and control strategies
to curb these infections.
Efforts are being made by many governmental and non-governmental
organizations to identify the patterns of development of STIs
in the community, which would help policy-makers to design appropriate
control measures.
References |
- Centers for Disease Control and Prevention. Summary
of notifiable diseases, United States, 1996. MMWR Morb
Mortal
Wkly Rep 1997;45:1–87.
- Global prevalence and
incidence of selected curable sexually transmitted
infections—overview
and estimates. Geneva: WHO; 2001.
- Mabey D. Sexually transmitted diseases
in developing countries. Trans R Soc Trop Med Hyg 1996;90:97–9.
- Panchaud C, Singh S, Fievelson D, Darroch JE. Sexually
transmitted diseases among adolescents in developed
countries. Fam Plann Perspect 2000;32:24–32.
- Fox
KK, Whittington WL, Levine WC, Moran JS, Zaidi AA, Nakashima
AK. Gonorrhoea in the United States,
1981–1996. Demographic and geographic trends.
Sex Transm Dis 1998;25:386–93.
- Hughes G, Andrews
N, Catchpole M, Goldman M, Forsyth-Benson D, Bond
M, et al. Investigation of the increased
incidence of gonorrhoea diagnosed
in genitourinary
medicine clinics in England, 1994–1996. Sex Transm Infect 2000;76:18–24.
- Eng TR, Butler WT. Reported rates of gonorrhea in selected
developed countries. In: The hidden epidemic: Confronting
sexually transmitted
diseases. Washington
DC:National Academy Press; 1997:29.
- Arya OP, Lawson JB. Sexually
transmitted diseases in the tropics. Epidemiological,
diagnostic, therapeutic and control aspects. Trop
Doct 1977;7:51–6.
- American Social Health Association. Sexually
transmitted diseases in America: How many cases and at what
cost? Menlo Park, CA:Kaiser
Family
Foundation; 1998.
- Finelli L, Levine WC, Valentine J, St Louis
ME. Syphilis outbreak assessment. Sex Transm Dis 2001;28:131–5.
- Centers for Disease Control and Prevention. Primary
and secondary syphilis—United
States, 1999. MMWR Morb Mortal Wkly Rep 2001;50:113–17.
- Division of STD Prevention. Sexually transmitted
disease prevention, 2000. Atlanta: Centers for Disease Control
and Prevention, US
Department of Health
and Human Services, Public Health Service; 2001.
- Kahn
RH, Heffelfinger JD, Berman SM. Syphilis outbreaks among
men who have sex with men. A public health trend
of concern. Sex Transm
Dis 2002;29:285–7.
- Fenton KA, Nicoll A, Kinghorn
G. Resurgence of syphilis in England: Time for more
radical and nationally coordinated
approaches.
Sex
Transm Infect 2001;77:309–10.
- Fennema JS, Cairo I, Coutinho
RA. [Substantial increase in gonorrhea and syphilis
among clients
of Amsterdam
Sexually Transmitted
Diseases
Clinic.] Ned Tijdschr
Geneeskd 2000;144:602–3.
- Rathore AS, Ray K,
Ramesh V, Mukherjee A. Periodic syphilis profile
in a New Delhi hospital. J Commun
Dis 1998;30:153–7.
- Khandpur S, Agarwal S, Kumar
S, Reddy BSN, Sharma VK. Clinico-epidemiological
profile and HIV seropositivity
of STD patients. Indian J Sex
Transm Dis 2001;22: 62–5.
- Reddy BSN, Jaitley
V. Profile of sexually transmitted diseases: A 14-year-study.
Indian J Sex Transm Dis 1985;6:37–40.
- Ganesh R, Stanley A, Ganesh N,
Venkatram MK, Alagappan R. Prevalence of neurosyphilis
at Government Rajaji
Hospital, Madurai, India.
Int J STD AIDS 1994;5:290–92.
- Kumar B, Handa S, Malhotra S.
Changing trends in sexually transmitted diseases.
Indian J Sex Transm
Dis 1995;16:24–7.
- Kumar B, Sharma VK, Malhotra
S. Pattern of sexually transmitted diseases in Chandigarh.
Indian J Dermtol
Venereol Leprol 1987;53:286–91.
- Gupta SK, Jain VK, Aggarwal
K. Trends of sexually transmitted diseases at Rohtak.
Indian J Sex Transm
Dis 1997;18:2–3.
- Aggarwal K, Jain VK, Brahma
D. Trend of STDs at Rohtak. Indian J Sex Transm
Dis 2002;23:19–21.
- Gupta SK, Jain VK. Pattern of
sexually transmitted diseases in Rohtak. Indian J
Sex Transm Dis 1995;16:28–9.
- Chopra A, Dhaliwal
RS, Chopra D. Pattern of changing trends of STDs
at Patiala. Indian J Sex Transm Dis 1999;20:22–5.
- Chopra A, Mittal RR, Singh P.
Pattern of sexually transmitted diseases in Patiala.
Indian J Sex Transm
Dis 1990;11:43–5.
- Pandit DD, Angadi SA, Chavan
MK, Pai NP. Prevalence of VDRL sero-positivity in
women in reproductive
age group in
an urban
slum community in
Bombay. Indian J Public Health 1995;39:4–7.
- Garg
S, Sharma N, Bhalla P, Sahay R, Saha R, Raina U,
et al. Reproductive morbidity in an Indian urban
slum: Need for
health
action. Sex Transm
Infect 2002;78:68–9.
- Bhargava NC, Ray K, Kumari
S. Incidence of HIV versus VDRL antibody positivity
in a major STD clinic
in Delhi.
Indian
J Sex Transm
Dis 1987;8:44–6.
- Nanu A, Sharma SP, Chatterjee
K, Jyoti P. Markers for transfusion-transmissible
infections in north
Indian voluntary
and replacement blood
donors: Prevalence and trends 1989–1996. Vox
Sang 1997;73:70–5.
- Nair D, Bhalla P, Mathur
MD. A study of antenatal screening for syphilis.
Indian J Sex Transm Dis 1996;17:54–6.
- Vajpayee
M, Seth P, Malhotra N. HIV and syphilis in pregnant
women at a tertiary care hospital. Trop
Doct 2001;31:56.
- Choudhury N, Ramesh V, Saraswat S, Naik
S. Effectiveness of mandatory transmissible diseases
screening in
Indian blood donors.
Indian J
Med Res 1995;101:229–32.
- Murugan S, Srinivasan
G, Kaleellulah MCA. Screening of blood donors for
syphilis. Indian J Sex Transm
Dis 1991;12:45–6.
- Gupta AK, Saran R. Detection
of antibodies to HIV-infection among high risk
group in Bihar, India.
Indian J Public
Health 1993;37:54–6.
- Garg S, Mathur DR, Garg
DK. Comparison of seropositivity of HIV, HBV, HCV
and syphilis in replacement and
voluntary blood
donors in
western
India. Indian
J Pathol Microbiol 2001;44:409–12.
- Gupta
N, Kaur A. Study of prevalence and correlation
between HIV and syphilis among blood donors in
a teaching hospital,
Ludhiana, India. Indian J Med
Sci 2002;56: 161–4.
- Mathai J, Sulochana PV,
Satyabhama S, Nair PK, Sivakumar S. Profile of
transfusion transmissible
infections
and associated risk factors
among blood
donors of Kerala.
Indian J Pathol Microbiol 2002;45:319–22.
- Sharma RR, Cheema R, Vajpayee M, Rao U, Kumar S,
Marwaha N, et al. Prevalence of markers of transfusion
transmissible
diseases
in
voluntary
and replacement
blood donors. Natl Med J India 2004;17:19–21.
- Sharma M, Kumar B, Sharma SK. Blood VDRL reactivity
in STD and antenatal clinics in Chandigarh. Indian
J Sex Transm
Dis 1986;7:14–15.
- Sharma M, Sethi S, Gopalan
S, Gulati K, Lyall S. Seroprevalence of reproductive
tract infections
in
women in northern
India—a relatively low prevalence
area. Sex Transm Infect 2003;79:497–8.
- Thakur
TS, Sharma V, Goyal A, Gupta ML. Seroprevalence
of HIV antibodies, Australia antigen and VDRL reactivity
in Himachal
Pradesh.
Indian J
Med Sci 1991;45:332–5.
- Chulki SF, Salam A,
Patil AM, Rukhsana SA. A study of STD seropositive
cases among blood donors.
Indian
J Sex
Transm Dis 2002;23:80–2.
- Rattan A, Maheshwari
N, Sharma R. Significance of low titre VDRL reactions.
Indian J Sex Transm
Dis 1987;8:5–6.
- Gupta N, Gautam V, Sehgal
R, Gill PS, Arora DR. Screening by VDRL test to
detect hidden cases
of
syphilis. Indian
J Med Microbiol 2003;21:118–20.
- Mathai E, Mathai M, Prakash
JA, Bergstrom S. Audit of management of pregnant
women with positive
VDRL
tests. Natl Med J India 2001;14:202–4.
- Harris VK, Nair SC, Das PK,
Sitaram U, Bose YN, Sudarsanam A, et al. Prevalence
of syphilis
and parasitic
infection
among blood
donors
in
a tertiary-care
centre in southern India. Ann Trop Med Parasitol 1999;93:763–5.
- Southwick KL, Blanco S, Santander
A, Estenssoro M, Torrico F, Seoane G, et al. Maternal
and congenital
syphilis
in
Bolivia, 1996:
Prevalence
and
risk factors.
Bull World Health Organ 2001;79:33–42.
- Anandam
K, Seethamma R. Variegated presentation of congenital
syphilis. Indian J Sex Transm Dis 1999;20:57–9.
- Tapsall JW. Surveillance of
antibiotic susceptibility of Neisseria gonorrhoeae
in the WHO Western Pacific
Region 1992–1994. WHO Western Pacific Region
Gonococcal Antimicrobial surveillance Programme.
Genitourin Med 1997;73:355–61.
- Singh R. Pattern
of VDs as seen at VD training demonstration center,
Safdarjung Hospital, New
Delhi. Indian J Dermatol
Venereol Leprol 1962;28:62–7.
- Narayan R, Kar HK. Pattern
of STDs in a Delhi Hospital. Indian J Sex Transm
Dis 1996;17:14–16.
- Raval RC, Desai N, Bilimoria
FE. Clinical profile of STDs at B.J. Medical College
and Civil Hospital,
Ahmedabad. Indian
J Sex
Transm
Dis 1995;16:54–5.
- Parmar J, Raval RC, Bilimoria
FE. Clinical profile of STDs at Civil Hospital
Ahmedabad. Indian J Sex
Transm Dis 2001;22:14–16.
- Ranganayakulu B, RaviKumar
GP, Bhaskar GV. Pattern of STDs at Kurnool. Indian
J Sex Transm Dis 1998;19:117–21.
- Reddy BSN,
Garg BR, Rao MV. An appraisal of trends in sexually
transmitted diseases. Indian
J Sex Transm
Dis 1993;14:1–4.
- Jaiswal AK, Singh G. Pattern
of sexually transmitted diseases in Jammu & Kashmir
region of India. Indian J Sex Transm Dis 1998;19:113–15.
- Sharma PK. A profile of sexually transmitted diseases
at Port Blair. Indian J Sex Transm Dis 1994;15:21–2.
- Jaiswal AK, Bhushan B. Pattern
of sexually transmitted diseases in North-Eastern
India. Indian J Sex Transm
Dis 1994;15:19–20.
- Divekar AA, Gogate AS,
Shivkar LK, Gogate S, Badhwar VR. Disease prevalence
in women attending
the STD
clinic in Mumbai,
India.
Int J STD AIDS 2000;11:
45–8.
- Kaur H, Saini JS, Jasmeen. Prevalence
of gonorrhoea in Punjabi women. J Obstet Gynecol
India 1995;45:100–5.
- Kaur S, Kumar B, Malhotra
S. Screening for gonococcal infection in patients
attending gynaecological
clinics. Indian J Sex
Transm Dis 1986;7:44–6.
- Hook EW 3rd, Holmes
KK. Gonococcal infections. Ann Intern Med 1985;102:
229–43.
- Over M, Piot P. HIV infection and
sexually transmitted diseases. In: Jamison DT (ed).
Disease control
priorities in developing
countries. New York:Oxford
University Press; 1993:455–67.
- Tchoudomirova
K, Nuhov PH, Tchapanova A. Prevalence, epidemiological
and clinical correlates of genital
Chlamydia trachomatis infection. J
Eur Acad Dermatol Venereol 1998;11:214–20.
- Gopalkrishna V, Aggarwal
N, Malhotra VL, Koranne RV, Mohan VP, Mittal A,
et al. Chlamydia trachomatis and
human papillomavirus
infection in Indian women
with sexually transmitted diseases and cervical
precancerous and
cancerous
lesions. Clin Microbiol Infect 2000;6:88–93.
- Rastogi S, Kapur S, Salhan S, Mittal A. Chlamydia
trachomatis infection in pregnancy: Risk factor
for an adverse outcome. Br J Biomed Sci 1999;56:94–8.
- Paul VK, Singh
M, Gupta U, Buckshee K, Bhargava VL, Takkar D,
et al. Chlamydia trachomatis infection
among
pregnant
women: Prevalence
and
prenatal importance. Natl Med J India 1999;12:11–14.
- Mittal A,
Kapur S, Gupta S. Screening for genital chlamydial
infection in symptomatic women. Indian
J Med Res 1993;98:119–23.
- Singh V, Sehgal
A, Satyanarayana L, Gupta MM, Parashari A, Chattopadhya
D. Clinical presentation
of gynaecologic
infections among Indian
women. Obstet Gynecol 1995;85:215–19.
- Joshi JV, Palayekar S, Hazari
KT, Shah RS, Chitlange SM. The prevalence of Chlamydia
trachomatis in
young women. Natl
Med
J India 1994;7:57–9.
- Brabin L, Gogate A,
Gogate S, Karande A, Khanna R, Dollimore N, et
al. Reproductive tract infections,
gynaecological
morbidity and
HIV seroprevalence
among women
in Mumbai, India. Bull World Health Organ 1998;76:277–87.
- Sharma M, Nayak N, Malhotra S, Kumar B, Hemal A.
Chlamydiazyme test for rapid detection of Chlamydia
trachomatis. Indian
J Med Res 1989;89:87–91.
- Mertz KJ, McQuillan
GM, Levine WC, Candal DH, Bullard JC, Johnson RE,
et al. A pilot study of
the prevalence
of chlamydial
infection
in a national
household
survey. Sex Transm Dis 1998;25:225–8.
- Stokes
T. Screening for Chlamydia in general practice:
A literature review and summary of the
evidence.
J Public Health
Med 1997;19:222–32.
- Bai H, Bo N, Huan Li,
Dong JZ. Prevalence of genital Chlamydia trachomatis
infection in selected
populations
in China. Sex
Transm Dis 1995;22:383–4.
- Thongkrajai P,
Thongkrajai E, Pengsaa P, Pakarasang M. The prevalence
of Chlamydia trachomatis infection
in rural
Thai
women. Southeast
Asian J Trop Med Public
Health 1999;30:52–7.
- Shrikhande SN, Joshi
SG, Zodpey SP, Saoji AM. Chlamydia trachomatis
in pelvic inflammatory disease.
Indian
J Pathol Microbiol 1995;38:181–4.
- Kamali
A, Nunn AJ, Mulder DW, Van Dyck E, Dobbins JG,
Whitworth JA. Seroprevalence and incidence
of genital ulcer
infections
in a rural Ugandan
population.
Sex Transm Infect 1999;75:98–102.
- Hira
SK. Sexually transmitted diseases in the era of
AIDS. AIDS watch—WHO
South-East Asia Region Newsletter 1997;2:1–2.
- Reddy BSN, Rao MV, Gharami RC. Clinico-epidemiological
study of donovanosis in Pondicherry. JIPMER
Bulletin 1994;13:14–17.
- O’Farrell N, Hammond
M. HLA antigens in donovanosis (Granuloma inguinale).
Genitourin Med 1991;67:400–2.
- Jamkhedkar
PP, Hira SK, Shroff HJ, Lanjewar DN. Clinico-epidemiologic
features of granuloma
inguinale
in the era of acquired
immune deficiency syndrome. Sex
Transm Dis 1998;25:196–200.
- Mehta Swami D,
Jaswal R, Bedi GK. Pattern of sexually transmitted
diseases in a new Northern
Indian Hospital.
Indian J Sex Transm
Dis 1998;19:109–12.
- Sehgal VN, Jain MK. Pattern
of epidemics of donovanosis in the ‘nonendemic’ region.
Int J Dermatol 1988;27:396–9.
- Abrams AJ.
Lymphogranuloma venereum. JAMA 1968;205:199–202.
- Mathew R, Kalyani J, Bibi R, Mallika M. Prevalence
of bacterial vaginosis in antenatal women. Indian
J Pathol Microbiol 2001;44:113–16.
- Purwar
M, Ughade S, Bhagat B, Agarwal V, Kulkarni H. Bacterial
vaginosis in early pregnancy and adverse
pregnancy
outcome.
J Obstet Gynaecol
Res 2001;27: 175–81.
- Vishwanath S, Talwar
V, Prasad R, Coyaji K, Elias CJ, de Zoysa I. Syndromic
management of vaginal
discharge
among
women
in a
reproductive health clinic
in India. Sex Transm Infect 2000;76:303–6.
- Aggarwal AK, Kumar R, Gupta V, Sharma M. Community
based study of reproductive tract infections among
ever married
women of
reproductive age in a rural
area of Haryana, India. J Commun Dis 1999;31:223–8.
- Bhatia JC, Cleland J, Bhagavan L, Rao NS. Levels
and determinants of gynecological morbidity in
a district of South India.
Stud Fam Plann 1997;28:95–103.
- Brugha R,
Keersmaeker SK, Renton A, Meheus A. Genital herpes
infection: A review. Int J Epidemiol 1997;26:698–709.
- Fleming DT, McQuillan GM,
Johnson RE, Nahmias AJ, Aral SO, Lee FK, et al.
Herpes simplex virus
type 2
in the United
States,
1976
to 1994.
N Engl
J Med 1997;337:1105–11.
- Risbud A, Chan-Tack K,
Gadkari D, Gangakhedkar RR, Shepherd ME, Bollinger
R, et al. The etiology
of genital
ulcer disease
by multiplex
polymerase
chain reaction and relationship to HIV infection
among patients attending sexually
transmitted disease clinics in Pune, India. Sex
Transm Dis 1999;26:55–612.
- Ambhore NA, Thakar
YS, Gaval SR. Seroprevalence of herpes simplex
virus type-2 in STD patients
with genital
ulcers.
Indian J Sex
Transm Dis 1998;19:81–4.
- Jacob M, Rao PS,
Sridharan G, John TJ. Epidemiology and clinical
profile of genital herpes. Indian
J Med Res 1989;89:4–11.
- Khanna J, van Look
PFA, Griffin PD. Reproductive health: A key to
a brighter future. Biennial report
1990–91. Geneva:World Health Organization;
1992.
- Koutsky L. Epidemiology of genital human
papillomavirus infection. Am J Med 1997;102:3–8.
- Saranath D, Khan Z, Tandle AT, Dedhia P, Sharma
B, Contractor R, et al. HPV 16/18 prevalence in
cervical lesions/cancers
and p53 genotypes
in cervical
cancer
patients from India. Gynecol Oncol 2002;86:157–62.
- Menon MM, Sinha MR, Doctor VM. Detection of human
papillomavirus (HPV) types in precancerous
and cancerous
lesions of cervix
in Indian women:
A preliminary
report. Indian J Cancer 1995;32:154–9.
- Chatterjee
R, Roy A, Basu S. Detection of type specific human
papillomavirus (HPV) DNA in cervical
cancers of
Indian women.
Indian J Pathol Microbiol 1995:38:33–42.
- Jamison JH, Kaplan DW, Hamman
R, Eagar R, Beach R, Douglas JM Jr. Spectrum of
genital human papillomavirus
infection
in a female
adolescent
population.
Sex Transm Dis 1995;22:236–43.
- Tanaka H,
Karube A, Tanaka T, Nakagomi O. Much higher risk
of premalignant and malignant cervical
diseases
in younger women positive
for HPV 16
than in older women positive for HPV 16. Microbiol
Immunol 2001;45:323–6.
- Tortolero-Luna G.
Epidemiology of genital human papillomavirus. Haematol
Oncol Clin North Am 1999;13:245–57.
- Vahrman
J. Transmission of hepatitis. Lancet 1970;2:774.
- Williams J, Shanmugasundraj. Prevalence of hepatitis
B among male homosexuals. Indian J Sex
Transm Dis 1989;10:6–9.
- Lodha R, Jain Y, Anand K,
Kabra SK, Pandav CS. Hepatitis B in India: A
review of disease
epidemiology. Indian
Pediatr 2001;38:349–71.
- Irshad M, Joshi
YK, Acharya SK, Tandon BN. Prevalence of hepatitis
B virus infection in
healthy persons
in North India.
Natl Med J
India 1994;7:210–12.
- Sumathy S, Thyagarajan
SP, Latif R, Madanagopalan N, Raguram K, Rajasambandam,
et al. A dipstick
immunobinding enzyme-linked
immunosorbent assay for
serodiagnosis of hepatitis B and delta virus
infections. J Virol Methods 1992;38: 145–52.
- Nayak NC, Panda SK, Zuckerman
AJ, Bhan MK, Guha DK. Dynamics and impact of
perinatal transmission
of hepatitis
B virus
in North India.
J Med Virol 1987;21:
137–45.
- Kulkarni ML, Reddy PV. Prevalence
of HBsAg in asymptomatic carrier mothers and
vertical
transmission in South
India. Am J Dis Child 1988;142:124–5.
- Duseja A, Arora L, Masih
B, Singh H, Gupta A, Behera D, et al. Hepatitis
B and C virus—prevalence
and prevention in health care workers. Trop
Gastroenterol 2002;23:125–6.
- Chandrasekaran S, Palaniappan
N, Krishnan V, Mohan G, Chandrasekaran N. Relative
prevalence
of hepatitis
B viral
markers and hepatitis
C antibodies (anti HCV)
in Madurai, south India. Indian J Med Sci 2000;54:270–3.
- Ganju SA, Goel A. Prevalence of HBV and HCV infection
among health care workers (HCWs). J
Commun Dis 2000;32:228–30.
- Tandon BN, Gandhi
BM, Joshi YK. Etiological spectrum of viral hepatitis
and prevalence of
markers of hepatitis
A and
B infection
in north India.
Bull World
Health Organ 1984;62:67–73.
- Singh H, Aggarwal
R, Singh RL, Naik SR, Naik S. Frequency of infection
by hepatitis B virus
and its
surface mutants
in a northern
Indian population.
Indian
J Gastroenterol 2003;22:132–7.
- Jain RC,
Bhat SD, Sangle S. Prevalence of hepatitis b
surface antigen among rural population
of Loni
area in Ahmednagar
district
of Western
Maharashtra. J Assoc Physicians India 1992;40:390–1.
- Joshi SH, Gorakshakar AC, Mukherjee M, Rao VR,
Sathe MS, Anabhavane SM, et al. Prevalence
of HBsAg
carriers
among some
tribes of Madhya
Pradesh. Indian J Med Res 1990;91:340–3.
- Reddy PH, Tedder
RS. Hepatitis virus markers in the Baiga tribal
population of Madhya Pradesh,
India.
Trans
R Soc Trop
Med Hyg 1995;89:620.
- Murhekar MV, Murhekar KM,
Arankalle VA, Sehgal SC. Epidemiology of hepatitis B
infection among
the Nicobarese—a mongoloid tribe of the
Andaman and Nicobar Islands, India. Epidemiol
Infect 2002;128:465–71.
- Murhekar MV,
Murhekar KM, Sehgal SC. Alarming prevalence
of hepatitis B infection among the
Jarawas—a primitive Negrito tribe of
the Andaman and Nicobar Islands, India. J
Viral Hepat 2003;10:232–3.
- Saha MK, Chakrabarti
S, Panda S, Naik TN, Manna B, Chatterjee A,
et al. Prevalence of
HCV and HBV
infection amongst HIV
seropositive intravenous drug users and
their non-injecting wives in Manipur, India.
Indian J
Med Res 2000;111: 37–9.
- Singh S, Prasad
R, Mohanty A. High-prevalence of sexually-transmitted
and blood-borne infections
among
the inmates of a district
jail in Northern India.
Int J STD AIDS 1999;10:475–8.
- Kar P,
Gangwal P, Budhiraja B, Singhal R, Jain A,
Madan K, et al. Analysis of serological
evidence
of different
hepatitis viruses
in
acute viral hepatitis
in prisoners in relation to risk factors. Indian
J Med Res 2000;112:128–32.
- Kelkar SS,
Phaltankar PG. Sexual transmission of hepatitis
B virus. J Assoc Physicians India 1982;30:99–100.
- Lenka MR, Ghosh E, Panja
SK. Prevalence of Australia antigen (HBsAg)
in STD. Indian
J Dermatol
Venereol
Leprol 1981;47:208–11.
- Singh V, Kumar
B, Bhasin DK. Prevalence of hepatitis B virus
and delta infection in
patients
with sexually
transmitted diseases
in North
India.
Indian J Sex Transm
Dis 1994;15:13–14.
- Marx MA, Murugavel
KG, Tarwater PM, SriKrishnan AK, Thomas DL,
Solomon S, et al. Association
of hepatitis C virus infection
with
sexual exposure
in southern
India. Clin Infect Dis 2003;37:514–20.
- Sherlock S, Dooley J. Hepatitis C virus, In:
Diseases of the liver and biliary system,
10th
ed., Oxford:
Blackwell Science;
1997:289–95.
- Gosavi MS, Shah SK, Shah
SR, Pal RB, Saldanha JA, Banker DD. Prevalence
of hepatitis C virus
(HCV) infection
in
Mumbai. Indian
J Med Sci 1997;51:378–85.
- Jaiswal SP,
Chitnis DS, Naik G, Artwani KK, Pandit CS,
Salgia P, et al. Prevalence
of anti-HCV
antibodies
in central
India.
Indian J
Med Res 1996;104:177–81.
- Chowdhury A, Santra
A, Chaudhuri S, Dhali GK, Chaudhuri S, Maity
SG, et al. Hepatitis
C virus
infection in
the general population:
A community-based study
in West Bengal, India. Hepatology 2003;37:802–9.
- Phukan AC, Sharma SK, Das HK, Mahanta J. HCV
activity in an isolated community in north
east
India. Indian
J Pathol Microbiol 2001;44:403–5.
- Thomas
K, Thyagarajan SP, Jeyaseelan I, Varghese JC,
Krishnamurthy P, Bai L, et al.
Community
prevalence of
sexually transmitted
diseases and human
immunodeficiency
virus infection in Tamil Nadu, India: A probability
proportional to size cluster survey. Natl
Med J India 2002;15:135–40.
- Chatterjee R,
Mukhopadhyay D, Murmu N, Jana S. Prevalence
of human papillomavirus
infection
among
prostitutes in
Calcutta. J
Environ Pathol
Toxicol Oncol 2001;20:113–17.
- Thawani
G, Singh US, Jana S. Prevalence of antibodies
to hepatitis-C virus among visitors
of red light
areas in Calcutta.
Indian J Sex
Transm Dis 1998;19:105–8.
- Urmil AC, Dutta
PK, Basappa K, Ganguly SS. A study of morbidity
pattern among prostitutes
attending
a
municipal clinic in Pune.
J Indian Med
Assoc 1989;87:
29–31.
- Lakshmi N, Kumar AG. HIV infection
among commercial sex workers. Indian J
Sex Transm
Dis 1994;15:11–12.
- Venketaramana CB,
Sarada PV. Extent and speed of spread of HIV
infection in India through
the
commercial sex network:
A
perspective. Trop Med
Int Health 2001;6:1040–61.
- Singh S, Thappa
DM, Jaisankar TJ. Risk factors in transmission
of HIV, hepatitis B,
C in STD
clinic attenders.
Indian
J Sex Transm Dis 2001;22:17–23.
- Singh S, Jaisankar TJ,
Thappa DM. Risk factors for transmission of
HIV infection among
STD clinic
attenders
at Pondicherry.
Indian J Sex
Transm Dis 2001;22: 27–30.
- Gawande AV,
Vasudeo ND, Zodpey SP, Khandait DW. Sexually
transmitted infections in long
distance truck drivers.
J Commun Dis 2000;32:212–15.
- Singh YN,
Malaviya AN. Long distance truck drivers in
India: HIV infection and their possible
role in
disseminating HIV
into rural areas.
Int J STD
AIDS 1994;5: 137–8.
- Biswas D, Hazarika
NC, Hazarika D, Mahanta J. Prevalence of communicable
diseases among
restaurant workers along
a highway in Assam, India.
Southeast Asian J Trop Med Public Health 1999;30:539–41.
- Baqi S, Shah SA, Baig MA, Mujeeb SA, Memon
A. Seroprevalence of HIV, HBV and syphilis
and associated
risk behaviours
in male transvestites (Hijras) in
Karachi, Pakistan. Int J STD AIDS 1999;10:300–4.
- Bourgois P, Dunlap E. Exorcising sex-for-crack:
An ethnographic perspective from Harlem. In:
Ratner M (ed). Crack pipe as
pimp: An ethnographic investigation
of the sex-for-crack exchange. New York, NY:Lexington;
1993:97–132.
- Agarwal AK, Singh GB, Khundom
KC, Singh ND, Singh T, Jana S. The prevalence
of HIV
in female
sex workers
in
Manipur, India. J Commun
Dis 1999; 31:23–8.
- Sharma AK, Aggarwal
OP, Dubey KK. Sexual behaviour of drug-users:
Is it different? Prev
Med 2002;34:512–15.
- Cook RL, Pollock
NK, Rao AK, Clark DB. Increased prevalence
of herpes simplex virus
type 2 among
adolescent women with
alcohol use
disorders.
J Adolesc Health 2002;30:169–74.
|
All India Institute of Medical Sciences, Ansari Nagar,
New Delhi 110029, India
vinod k. sharma, SUJAY KHANDPUR Department of Dermatology
and Venereology
Correspondence to vinod k. sharma; aiimsvks@yahoo.com
|
|